Skip to content

Study shows that use of darunavir/ritonavir and etravirine in HIV treatment as a prevention method is biologically plausible

World Health Organization sets out route map for scale-up of treatment as prevention

Big delays in switching to second-line ART in South Africa

Starting HIV treatment with a CD4 cell count below 350 associated with a key marker of cardiovascular risk

HIV treatment breaks lead to drug resistance in the female genital tract

NICE says sperm washing is no safer than effective treatment and timed intercourse

Canadian cohort shows viral suppression most likely with atazanavir/ritonavir-based HIV treatment after 6 months

Black race and depression associated with poorer adherence to HIV treatment

Co-infection with hepatitis C increases mortality risk by 50% for patients with AIDS